Skip to content

Medications

Does Wellbutrin cause weight loss

Most antidepressants are known for nudging weight up, but bupropion is the odd one out: it's the only one that's also part of an FDA-approved weight-loss pill.

A doctor on the phone while working on a laptop
Photo: Vitaly Gariev / Unsplash

The short answer

For some people, yes, a little. Wellbutrin (bupropion) tends to be weight-neutral or lead to modest weight loss, which sets it apart from many antidepressants that are more often linked to gain.

It works differently from SSRIs like Zoloft or Lexapro. Bupropion acts mainly on dopamine and norepinephrine, which can take the edge off appetite for some people.

Bupropion is FDA-approved for depression, for preventing seasonal depression, and, as Zyban, to help people quit smoking. Weight change is a side effect, not the goal of treatment.

How it compares with newer options

Bupropion's weight effect is real but modest. Here's how the approved weight-management medicines stack up in their main trials, as average loss over about a year to 18 months:

MedicineHow it's takenAverage loss in main trial
Contrave (naltrexone/bupropion)Tablets, twice dailyAbout 5% to 6%
Wegovy (semaglutide)Weekly injectionAbout 14.9% (STEP 1)
Zepbound (tirzepatide)Weekly injectionUp to about 20.9% (SURMOUNT-1)

These were separate trials with different people, so they aren't a head-to-head result. For a direct look at the two injections, see Zepbound vs Wegovy.

Side effects to know

Common ones include dry mouth, trouble sleeping, headache, nausea and constipation. Taking it earlier in the day can help with sleep. Heavy drinking raises seizure risk, so be honest with your prescriber about alcohol.

How much weight people lose

On bupropion alone, any loss is usually small, a few pounds on average in studies, and many people see no change at all. It isn't approved by the FDA as a weight-loss medicine on its own.

The bigger effect comes from Contrave, a tablet that combines bupropion with naltrexone. It's FDA-approved for chronic weight management. In its main trials, people lost roughly 5% to 6% of body weight on average over about a year, compared with about 1% to 2% on placebo. That's real, but smaller than newer options like Zepbound or Wegovy.

What the research says

Here's an honest look at how strong the evidence is:

  • Bupropion alone: modest and mixed. In the label's placebo-controlled depression trials, losing more than 5 lb was more common on bupropion than on placebo. Smaller studies in adults with obesity found a few percent more loss than placebo, but they were short and few
  • Compared with other antidepressants: fairly consistent. Large studies of health records suggest people starting bupropion tend to gain less over time than people starting most SSRIs. These studies show patterns, not proof of cause
  • Contrave: stronger. Several large, year-long randomized trials support the 5% to 6% average loss described above

Averages also hide a wide range. Some people lose more, and many lose little or nothing.

A worked example with numbers

Say you weigh 220 lb. Based on the Contrave trial averages, here's roughly what a year might look like:

GroupAverage lossFor a 220 lb person
Contrave plus diet and activity adviceAbout 5% to 6%About 11 to 13 lb
Placebo plus diet and activity adviceAbout 1% to 2%About 2 to 4 lb

Even 5% can improve blood pressure and blood sugar for many people. The Contrave label asks prescribers to check progress after about 12 weeks on the full dose and to reassess if loss is under 5%.

To see what 5% means at your weight, try the weight-loss projection tool or the plan for losing 10 pounds.

Who shouldn't take it

The label lists people who should avoid bupropion, including anyone with:

  • A seizure disorder, because bupropion lowers the seizure threshold
  • A current or past eating disorder such as bulimia or anorexia
  • Abrupt withdrawal from alcohol, benzodiazepines or seizure medicines
  • Use of an MAO inhibitor in the past 14 days

Like all antidepressants, it carries a boxed warning about suicidal thoughts in young people. Your prescriber will weigh that with you.

Contrave adds a few more because of the naltrexone. It shouldn't be used with long-term opioid medicines, with uncontrolled high blood pressure or during pregnancy. It carries the same boxed warning about suicidal thoughts.

If weight is your goal

Don't start or switch an antidepressant just for weight. Your mood comes first, and the right medicine for you depends on your history and other prescriptions.

If you want help with weight too, it's worth an honest conversation about the options built for it. Our roundup of weight-loss medications and the BMI and eligibility calculator are good places to start.

When to talk to your doctor

  • You notice weight changes you didn't expect, up or down, after starting or changing a dose
  • You want to switch or stop an antidepressant. Stopping suddenly can cause withdrawal-like symptoms
  • Your mood gets worse, or you have thoughts of harming yourself. Call or text 988 any time
  • You're considering a weight-loss medicine alongside your current prescriptions

Run your numbers

Keep reading

Common questions

Does Wellbutrin make you lose weight?

It can lead to modest weight loss for some people, while many see no change. It isn't approved as a weight-loss medicine on its own.

Is Contrave the same as Wellbutrin?

No. Contrave combines bupropion with naltrexone in a different formulation, and it's FDA-approved for chronic weight management.

Can I ask for Wellbutrin to lose weight?

You can raise it with your prescriber, but it's prescribed for depression and smoking cessation. They'll look at whether it fits your health history.

How long does it take to notice weight changes on Wellbutrin?

It varies. Appetite changes, if any, often show up in the first weeks, but a weight trend takes a couple of months to read. Track weekly averages and share them with your prescriber.

Sources

  1. Wellbutrin prescribing information (DailyMed)
  2. Contrave prescribing information (DailyMed)
  3. NIDDK: weight management

Clinician review pending. Drafted from primary sources and waiting for sign-off by a licensed clinician (MD, DO or PharmD) before launch. Every number is checked against its source. Drug facts are re-checked quarterly, prices monthly and whenever a label changes. How we review · Report an error